Dieter Hoersch

Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT

Vikas Prasad, Valentina Ambrosini, Merten Hommann et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 248 citations

Medicine, Nuclear Medicine, Oncology +12

Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases

Nicole Posorski, Daniel Kaemmerer, G Ernst et al. · Clinical & Experimental Metastasis · 2011 · 30 citations

Medicine, Cancer Biology, Oncology +14

Updated overall survival (OS) and progression-free survival (PFS) by blinded independent central review (BICR) of sunitinib (SU) versus placebo (PBO) for patients (Pts) with advanced unresectable pancreatic neuroendocrine tumors (NET).

Éric Raymond, Patricia Niccoli, Jean‐Luc Raoul et al. · Journal of Clinical Oncology · 2011 · 25 citations

Medicine, Oncology, Pharmacology +14

Everolimus plus octreotide LAR (E+O) versus placebo plus octreotide LAR (P+O) in patients with advanced neuroendocrine tumors (NET): Updated results of a randomized, double-blind, placebo-controlled, multicenter phase III trial (RADIANT-2).

James C. Yao, John D. Hainsworth, Éric Baudin et al. · Journal of Clinical Oncology · 2011 · 21 citations

Medicine, Oncology, Pharmacology +17

Characterization of [Phe13, Tyr19]-MCH analog binding activity to the MCH receptor

E. Kokkotou, Jason Mastaitis, Daqing Qu et al. · Neuropeptides · 2000 · 19 citations

Medicine, Medicinal Chemistry, Pharmacology +12